Back to VRTX
Bellevue Group AG VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
8
Latest value
$291.4M
Q3 2026
Peak value
$302.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $6.2M |
| Q4 2025 | $302.6M |
| Q1 2026 | $6.5M |
| Q1 2026 | $298M |
| Q2 2026 | $10.6M |
| Q2 2026 | $276.9M |
| Q3 2026 | $11.1M |
| Q3 2026 | $291.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $291.4M | 557.4K | — | — |
| Q3 2026 | $11.1M | 21.2K | — | — |
| Q2 2026 | $276.9M | 557.4K | — | — |
| Q2 2026 | $10.6M | 21.3K | — | — |
| Q1 2026 | $298M | 667.4K | — | — |
| Q1 2026 | $6.5M | 14.5K | — | — |
| Q4 2025 | $302.6M | 667.4K | — | — |
| Q4 2025 | $6.2M | 13.7K | — | — |